Giordano, C. and Picardi, M. (2020) “Early Intensification with bendamustine supercharge plus brentuximab vedotinfollowing failure to obtain complete metabolic remission after two cycles of ABVD inpatients aged ≤60 years with classic Hodgkin lymphoma. Comment on:‘Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkinlymphoma: the LYSA real-world experience’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301273.